![Steroid-sparing effects of fluticasone propionate 100 μg and salmeterol 50 μg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 μg administered twice daily - Journal Steroid-sparing effects of fluticasone propionate 100 μg and salmeterol 50 μg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 μg administered twice daily - Journal](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ca92e379-083a-4e47-849d-8d99eec04f75/gr1.jpg)
Steroid-sparing effects of fluticasone propionate 100 μg and salmeterol 50 μg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 μg administered twice daily - Journal
![Raltegravir (RAL) 1200 mg Once Daily (QD) is Non-Inferior to RAL 400 mg Twice Daily (BID), in Combination with Tenofovir/Emtricitabine, in Treatment-Naïve HIV-1 Infected Subjects: Week 48 Results Raltegravir (RAL) 1200 mg Once Daily (QD) is Non-Inferior to RAL 400 mg Twice Daily (BID), in Combination with Tenofovir/Emtricitabine, in Treatment-Naïve HIV-1 Infected Subjects: Week 48 Results](https://www.natap.org/2016/images/072916/072916-3/IAC1.gif)
Raltegravir (RAL) 1200 mg Once Daily (QD) is Non-Inferior to RAL 400 mg Twice Daily (BID), in Combination with Tenofovir/Emtricitabine, in Treatment-Naïve HIV-1 Infected Subjects: Week 48 Results
![Once-daily prolonged-release tacrolimus versus twice-daily tacrolimus in liver transplantation - Journal of the American Pharmacists Association Once-daily prolonged-release tacrolimus versus twice-daily tacrolimus in liver transplantation - Journal of the American Pharmacists Association](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/fd7317d4-a966-400d-a8c2-4baebd7b1ff2/gr1.jpg)
Once-daily prolonged-release tacrolimus versus twice-daily tacrolimus in liver transplantation - Journal of the American Pharmacists Association
![Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): a meta-analysis of randomized clinical trials - Radiotherapy and Oncology Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): a meta-analysis of randomized clinical trials - Radiotherapy and Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/d87e56a5-1c6e-4385-aba8-b21849591cca/gr1.jpg)
Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): a meta-analysis of randomized clinical trials - Radiotherapy and Oncology
PLOS ONE: Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach
![Cancers | Free Full-Text | Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center | HTML Cancers | Free Full-Text | Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center | HTML](https://www.mdpi.com/cancers/cancers-14-01330/article_deploy/html/images/cancers-14-01330-g001.png)
Cancers | Free Full-Text | Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center | HTML
Spectrum Pharmaceuticals Presents Twice Daily Dosing Data for Poziotinib at the ESMO TAT Virtual Congress 2021
![Medical Terminology How much do you know?. 24 Hour Clock Write out the times 10:40 pm 6:35 am 4:49 pm 12:50 pm 11:05 am If you have a basketball game. - ppt download Medical Terminology How much do you know?. 24 Hour Clock Write out the times 10:40 pm 6:35 am 4:49 pm 12:50 pm 11:05 am If you have a basketball game. - ppt download](https://images.slideplayer.com/24/7554031/slides/slide_7.jpg)
Medical Terminology How much do you know?. 24 Hour Clock Write out the times 10:40 pm 6:35 am 4:49 pm 12:50 pm 11:05 am If you have a basketball game. - ppt download
PLOS ONE: Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach
![Exenatide Twice Daily Plus Glargine Versus Aspart 70/30 Twice Daily in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Premixed Human Insulin and Metformin - Endocrine Practice Exenatide Twice Daily Plus Glargine Versus Aspart 70/30 Twice Daily in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Premixed Human Insulin and Metformin - Endocrine Practice](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/dff88bc4-9a2c-4486-a0e7-512cca1f1a71/gr1.jpg)